Yifan Zhai
Chief Tech/Sci/R&D Officer at ASCENTAGE PHARMA GROUP INTERNATIONAL
Net worth: 148 M $ as of 2024-04-29
Profile
Yifan Zhai is a Chief Medical Officer at Ascentage Pharma Group International Co., Ltd.
She previously held positions as Director-Pharmacology Department at Exelixis, Inc., President at HealthQuest, Inc., Chief Scientific Officer at Celladon Corp.
and Oncomax Acquisition Corp.
She was also President of The Chinese Biopharmaceutical Association.
She worked as a Principal at Human Genome Sciences, Inc. and Bayer Pharmaceuticals Corp.
Zhai holds a doctorate degree from Michigan State University and Sun Yat-Sen University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-10-26 | 64,585,929 ( 22.25% ) | 148 M $ | 2024-04-29 |
Yifan Zhai active positions
| Companies | Position | Start |
|---|---|---|
| ASCENTAGE PHARMA GROUP INTERNATIONAL | Chief Tech/Sci/R&D Officer | 2013-06-30 |
Former positions of Yifan Zhai
| Companies | Position | End |
|---|---|---|
| The Chinese Biopharmaceutical Association | President | 2009-12-31 |
Celladon Corp.
 Celladon Corp. BiotechnologyHealth Technology Celladon Corp. is a clinical-stage biotechnology company, engaging in the development of cardiovascular gene therapy. The company's therapeutic portfolio for diseases characterized by SERCA enzyme deficiency includes both gene therapies and small molecule compounds. Its most advanced product candidate MYDICAR uses gene therapy to target SERCA2a, an enzyme that is deficient in heart failure patients. Celladon was founded by Roger J. Hajjar and Kenneth R. Chien on December 21, 2000 and is headquartered in San Diego, CA. | Chief Tech/Sci/R&D Officer | 2009-12-31 |
| Oncomax Acquisition Corp. | Chief Tech/Sci/R&D Officer | 2006-12-31 |
HealthQuest, Inc.
 HealthQuest, Inc. Medical/Nursing ServicesHealth Services HealthQuest, Inc. provides health care and well-being awareness services. The company is headquartered in Palm Beach Gardens, FL. | President | 2004-12-31 |
| EXELIXIS, INC. | Corporate Officer/Principal | 2002-12-31 |
Training of Yifan Zhai
| Michigan State University | Doctorate Degree |
| Sun Yat-Sen University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| EXELIXIS, INC. | Health Technology |
| ASCENTAGE PHARMA GROUP INTERNATIONAL | Health Technology |
| Private companies | 6 |
|---|---|
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Health Technology |
Celladon Corp.
Celladon Corp. BiotechnologyHealth Technology Celladon Corp. is a clinical-stage biotechnology company, engaging in the development of cardiovascular gene therapy. The company's therapeutic portfolio for diseases characterized by SERCA enzyme deficiency includes both gene therapies and small molecule compounds. Its most advanced product candidate MYDICAR uses gene therapy to target SERCA2a, an enzyme that is deficient in heart failure patients. Celladon was founded by Roger J. Hajjar and Kenneth R. Chien on December 21, 2000 and is headquartered in San Diego, CA. | Health Technology |
| Bayer Pharmaceuticals Corp. | |
HealthQuest, Inc.
HealthQuest, Inc. Medical/Nursing ServicesHealth Services HealthQuest, Inc. provides health care and well-being awareness services. The company is headquartered in Palm Beach Gardens, FL. | Health Services |
| The Chinese Biopharmaceutical Association | |
| Oncomax Acquisition Corp. |
- Stock Market
- Insiders
- Yifan Zhai
